Mobile Health Use by Older Individuals at Risk of Cardiovascular Disease and Type 2 Diabetes Mellitus in an Australian Cohort: Cross-sectional Survey Study.
aging
cardiovascular
cardiovascular diseases
cohort studies
diabetes
diabetes mellitus type 2
digital health
mHealth
mobile app
mobile applications
mobile health
telemedicine
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
07 09 2022
07 09 2022
Historique:
received:
18
02
2022
accepted:
24
08
2022
revised:
15
07
2022
entrez:
7
9
2022
pubmed:
8
9
2022
medline:
11
9
2022
Statut:
epublish
Résumé
The digital transformation has the potential to change health care toward more consumers' involvement, for example, in the form of health-related apps which are already widely available through app stores. These could be useful in helping people understand their risk of chronic conditions and helping them to live more healthily. With this study, we assessed mobile health app use among older Australians in general and among those who were at risk of cardiovascular disease or type 2 diabetes mellitus. In this cross-sectional analysis, we used data from the second follow-up wave of the 45 and Up Study. It is a cohort study from New South Wales, Australia, with 267,153 participants aged 45 years and older that is based on a random sample from the Services Australia (formerly the Australian Government Department of Human Services) Medicare enrollment database. The 2019 follow-up questionnaire contained questions about technology and mobile health use. We further used data on prescribed drugs and hospitalizations to identify participants who already had cardiovascular disease or diabetes or who were at risk of these conditions. Our primary outcome measure was mobile health use, defined as having used a mobile health app before. We used descriptive statistics and multivariate logistic regression to answer the research questions. Overall, 31,946 individuals with a median age of 69 (IQR 63-76) years had completed the follow-up questionnaire in 2019. We classified half (16,422/31,946, 51.41%) of these as being at risk of cardiovascular disease or type 2 diabetes mellitus and 38.04% (12,152/31,946) as having cardiovascular disease or type 1 or type 2 diabetes mellitus. The proportion of mobile health app users among the at-risk group was 31.46% (5166/16,422) compared to 29.16% (9314/31,946) in the total sample. Those who used mobile health apps were more likely to be female, younger, without physical disability, and with a higher income. People at risk of cardiovascular disease or type 2 diabetes mellitus were not statistically significantly more likely to use mobile health than were people without risk (odds ratio 1.06, 95% CI 0.97-1.16; P=.18; adjusted for age, sex, income, and physical disability). People at risk of cardiovascular disease or type 2 diabetes mellitus were not more likely to use mobile health apps than were people without risk. Those who used mobile health apps were less likely to be male, older, with a physical disability, and with a lower income. From the results, we concluded that aspects of equity must be considered when implementing a mobile health intervention to reach all those that can potentially benefit from it.
Sections du résumé
BACKGROUND
The digital transformation has the potential to change health care toward more consumers' involvement, for example, in the form of health-related apps which are already widely available through app stores. These could be useful in helping people understand their risk of chronic conditions and helping them to live more healthily.
OBJECTIVE
With this study, we assessed mobile health app use among older Australians in general and among those who were at risk of cardiovascular disease or type 2 diabetes mellitus.
METHODS
In this cross-sectional analysis, we used data from the second follow-up wave of the 45 and Up Study. It is a cohort study from New South Wales, Australia, with 267,153 participants aged 45 years and older that is based on a random sample from the Services Australia (formerly the Australian Government Department of Human Services) Medicare enrollment database. The 2019 follow-up questionnaire contained questions about technology and mobile health use. We further used data on prescribed drugs and hospitalizations to identify participants who already had cardiovascular disease or diabetes or who were at risk of these conditions. Our primary outcome measure was mobile health use, defined as having used a mobile health app before. We used descriptive statistics and multivariate logistic regression to answer the research questions.
RESULTS
Overall, 31,946 individuals with a median age of 69 (IQR 63-76) years had completed the follow-up questionnaire in 2019. We classified half (16,422/31,946, 51.41%) of these as being at risk of cardiovascular disease or type 2 diabetes mellitus and 38.04% (12,152/31,946) as having cardiovascular disease or type 1 or type 2 diabetes mellitus. The proportion of mobile health app users among the at-risk group was 31.46% (5166/16,422) compared to 29.16% (9314/31,946) in the total sample. Those who used mobile health apps were more likely to be female, younger, without physical disability, and with a higher income. People at risk of cardiovascular disease or type 2 diabetes mellitus were not statistically significantly more likely to use mobile health than were people without risk (odds ratio 1.06, 95% CI 0.97-1.16; P=.18; adjusted for age, sex, income, and physical disability).
CONCLUSIONS
People at risk of cardiovascular disease or type 2 diabetes mellitus were not more likely to use mobile health apps than were people without risk. Those who used mobile health apps were less likely to be male, older, with a physical disability, and with a lower income. From the results, we concluded that aspects of equity must be considered when implementing a mobile health intervention to reach all those that can potentially benefit from it.
Identifiants
pubmed: 36069764
pii: v10i9e37343
doi: 10.2196/37343
pmc: PMC9494219
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e37343Informations de copyright
©Vera Helen Buss, Marlien Varnfield, Mark Harris, Margo Barr. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 07.09.2022.
Références
Int J Epidemiol. 2008 Oct;37(5):941-7
pubmed: 17881411
Int J Epidemiol. 2022 May 23;:
pubmed: 35604374
J Med Internet Res. 2020 Aug 13;22(8):e18476
pubmed: 32788144
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
J Am Heart Assoc. 2019 Dec 17;8(24):e014390
pubmed: 31818220
JMIR Mhealth Uhealth. 2018 Apr 26;6(4):e103
pubmed: 29699971
BMC Med Res Methodol. 2017 May 8;17(1):80
pubmed: 28482809
J Med Internet Res. 2018 May 02;20(5):e177
pubmed: 29720359
Int J Obes (Lond). 2014 Jun;38(6):848-56
pubmed: 24149770
Int J Epidemiol. 2011 Dec;40(6):1652-66
pubmed: 22158673
Health Commun. 2019 Oct;34(11):1320-1328
pubmed: 29889560
BMC Health Serv Res. 2013 Nov 19;13:481
pubmed: 24245780
J Med Syst. 2016 Jun;40(6):153
pubmed: 27147516
Prev Sci. 2013 Aug;14(4):319-51
pubmed: 23430579
BMC Med Res Methodol. 2010 Apr 01;10:26
pubmed: 20356408
Aust N Z J Public Health. 2011 Dec;35(6):557-63
pubmed: 22151163
Health Promot Int. 2021 Aug 30;36(4):1105-1115
pubmed: 33367568
J Med Internet Res. 2017 Apr 19;19(4):e125
pubmed: 28428170
J Med Internet Res. 2020 May 14;22(5):e16299
pubmed: 32406865
JMIR Mhealth Uhealth. 2017 Dec 19;5(12):e197
pubmed: 29258981
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Int J Epidemiol. 2015 Aug;44(4):1172-80
pubmed: 25502107
Lancet. 2013 Feb 23;381(9867):690-7
pubmed: 23410609
Mhealth. 2017 Sep 14;3:38
pubmed: 29184890